Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON

TANGO THERAPEUTICS, INC.

(TNGX)
RiassuntoQuotazioniGraficiNotizieRatingAgendaSocietąFinanzaConsensusRevisioniDerivati 
 RiassuntoTutte le notizieRaccomandazione analistiAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settore
Tutte le notizie su TANGO THERAPEUTICS, INC.
09/11Tango Therapeutics riporta una perdita netta più contenuta nel terzo trimestre
MT
09/11Guadagni Flash (TNGX) TANGO THERAPEUTICS Posts Q3 entrate $6.8M
MT
20/09TANGO THERAPEUTICS, INC.: SVB Leerink rimane Buy
MM
07/09TANGO THERAPEUTICS, INC.: Guggenheim ancora positivo
MM
07/09TANGO THERAPEUTICS, INC.: Barclays ancora positivo
MM
07/09TANGO THERAPEUTICS, INC.: Wedbush ottimista sul caso
MM
07/09TANGO THERAPEUTICS, INC.: Goldman Sachs rimane Buy
MM
Tutte le notizie
Notizie in altre lingue su TANGO THERAPEUTICS, INC.
11/11Tango Therapeutics to Participate in the Jefferies London Healthcare Conference
09/11TANGO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition a..
09/11Tango Therapeutics Corporate Presentation
09/11Tango Therapeutics Reports Narrower Q3 Net Loss
09/11Tango Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business H..
09/11Earnings Flash (TNGX) TANGO THERAPEUTICS Reports Q3 Loss $-0.28
09/11Earnings Flash (TNGX) TANGO THERAPEUTICS Posts Q3 Revenue $6.8M
09/11Tango Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business H..
02/11Tango Therapeutics Corporate Presentation
01/11Tango Therapeutics Announces Appointment of Dr. Marc Rudoltz as Chief Medical Officer a..
Pił notizie
Raccomandazione degli analisti su TANGO THERAPEUTICS, INC.
20/09TANGO THERAPEUTICS, INC.: SVB Leerink rimane Buy
MM
07/09TANGO THERAPEUTICS, INC.: Guggenheim ancora positivo
MM
07/09TANGO THERAPEUTICS, INC.: Barclays ancora positivo
MM
07/09TANGO THERAPEUTICS, INC.: Wedbush ottimista sul caso
MM
07/09TANGO THERAPEUTICS, INC.: Goldman Sachs rimane Buy
MM
Pił raccomandazioni
Prossimi eventi del settore